From: Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast
Factors | DFS Hazard ratio (95Â % CI) | P value | OS Hazard ratio (95Â % CI) | P value |
---|---|---|---|---|
Univariate analyses | ||||
 Age | 1.172(0.851–1.616) | 0.331 | 1.162(0.844–1.601) | 0.358 |
 Menopausal status | 1.015(0.831–1.239) | 0.885 | 1.016(0.831–1.242) | 0.878 |
 Molecular type | 1.373(0.995–1.896) | 0.054 | 1.385(1.004–1.912) | 0.047* |
 Tumor stage | 0.685(0.590–0.796) | 0.000** | 0.694(0.599–0.805) | 0.000** |
 LN metastasis | 1.287(0.927–1.786) | 0.131 | 1.335(0.961–1.855) | 0.085 |
 ER | 1.171(0.848–1.616) | 0.338 | 1.163(0.843–1.605) | 0.359 |
 PR | 1.016(0.736–1.404) | 0.922 | 1.048(0.760–1.446) | 0.774 |
 Her2 | 1.646(1.186–2.285) | 0.003** | 1.740(1.245–2.431) | 0.001** |
 Ki-67 | 1.058(0.765–1.4622) | 0.734 | 1.075(0.777–1.485) | 0.663 |
 Tiam1 | 1.781(1.276–2.487) | 0.001** | 1.671(1.204–2.320) | 0.002** |
Multivariate analyses | ||||
 Tiam1 | 1.470(1.056–2.047) | 0.022* | 1.549(1.112–2.157) | 0.010* |
 Molecular type | 1.340(0.963–1.865) | 0.082 | ||
 Tumor stage | 0.567(0.413–0.778) | 0.000** | 0.585(0.425–0.805) | 0.001** |
 Her2 | 0.585(0.290–1.179) | 0.134 | 0.617(0.298–1.276) | 0.617 |